Literature DB >> 12117999

Hsp90 interactions and acylation target the G protein Galpha 12 but not Galpha 13 to lipid rafts.

Abdul A Waheed1, Teresa L Z Jones.   

Abstract

The heterotrimeric G proteins, G(12) and G(13), are closely related in their sequences, signaling partners, and cellular effects such as oncogenic transformation and cytoskeletal reorganization. Yet G(12) and G(13) can act through different pathways, bind different proteins, and show opposing actions on some effectors. We investigated the compartmentalization of G(12) and G(13) at the membrane because other G proteins reside in lipid rafts, membrane microdomains enriched in cholesterol and sphingolipids. Lipid rafts were isolated after cold, nonionic detergent extraction of cells and gradient centrifugation. Galpha(12) was in the lipid raft fractions, whereas Galpha(13) was not associated with lipid rafts. Mutation of Cys-11 on Galpha(12), which prevents its palmitoylation, partially shifted Galpha(12) from the lipid rafts. Geldanamycin treatment, which specifically inhibits Hsp90, caused a partial loss of wild-type Galpha(12) and a complete loss of the Cys-11 mutant from the lipid rafts and the appearance of a higher molecular weight form of Galpha(12) in the soluble fractions. These results indicate that acylation and Hsp90 interactions localized Galpha(12) to lipid rafts. Hsp90 may act as both a scaffold and chaperone to maintain a functional Galpha(12) only in discrete membrane domains and thereby explain some of the nonoverlapping functions of G(12) and G(13) and control of these potent cell regulators.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117999     DOI: 10.1074/jbc.C200383200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

Review 1.  Heterotrimeric G protein signaling outside the realm of seven transmembrane domain receptors.

Authors:  Caroline Marty; Richard D Ye
Journal:  Mol Pharmacol       Date:  2010-04-19       Impact factor: 4.436

2.  Scavenger receptor BI modulates platelet reactivity and thrombosis in dyslipidemia.

Authors:  Yi Ma; Mohammad Z Ashraf; Eugene A Podrez
Journal:  Blood       Date:  2010-05-27       Impact factor: 22.113

Review 3.  Regulation and physiological functions of G12/13-mediated signaling pathways.

Authors:  Nobuchika Suzuki; Nicole Hajicek; Tohru Kozasa
Journal:  Neurosignals       Date:  2009-02-12

4.  G alpha12 is targeted to the mitochondria and affects mitochondrial morphology and motility.

Authors:  Alexandra V Andreeva; Mikhail A Kutuzov; Tatyana A Voyno-Yasenetskaya
Journal:  FASEB J       Date:  2008-03-26       Impact factor: 5.191

5.  Contribution of the P2Y12 receptor-mediated pathway to platelet hyperreactivity in hypercholesterolemia.

Authors:  B Nagy; J Jin; B Ashby; M P Reilly; S P Kunapuli
Journal:  J Thromb Haemost       Date:  2011-04       Impact factor: 5.824

Review 6.  Signalling mechanisms of RhoGTPase regulation by the heterotrimeric G proteins G12 and G13.

Authors:  Tohru Kozasa; Nicole Hajicek; Christina R Chow; Nobuchika Suzuki
Journal:  J Biochem       Date:  2011-08-26       Impact factor: 3.387

7.  Molecular chaperoning function of Ric-8 is to fold nascent heterotrimeric G protein α subunits.

Authors:  Puiyee Chan; Celestine J Thomas; Stephen R Sprang; Gregory G Tall
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

Review 8.  Ric-8 regulation of heterotrimeric G proteins.

Authors:  Gregory G Tall
Journal:  J Recept Signal Transduct Res       Date:  2013-02-06       Impact factor: 2.092

9.  Gα12 structural determinants of Hsp90 interaction are necessary for serum response element-mediated transcriptional activation.

Authors:  Ellyn R Montgomery; Brenda R S Temple; Kimberly A Peters; Caitlin E Tolbert; Brandon K Booker; Joseph W Martin; Tyler P Hamilton; Alicia C Tagliatela; William C Smolski; Stephen L Rogers; Alan M Jones; Thomas E Meigs
Journal:  Mol Pharmacol       Date:  2014-01-16       Impact factor: 4.436

10.  Galpha(s) is palmitoylated at the N-terminal glycine.

Authors:  Christiane Kleuss; Eberhard Krause
Journal:  EMBO J       Date:  2003-02-17       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.